Dennis Weissman is a widely respected independent analyst, consultant and thought leader who has worked in the clinical laboratory and anatomic pathology sectors for over three decades. Having founded a national information company focusing on the diagnostic industry, he is now actively engaged in providing M&A advisory services for lab and AP organizations, serves in an advisory role with a variety of diagnostic companies and remains a popular conference and workshop speaker before state, regional and national healthcare organizations.
- England & Company
Mr. Weissman serves as a senior healthcare advisor to England & Company, a DC-based investment bank focused on providing M&A advisory, financial restructuring, and capital raising services to middle market healthcare companies with a concentration in anatomic and clinical diagnostic laboratories, medical devices, IT and other healthcare services.
- Slone Partners
Mr. Weissman serves on the advisory board at Slone Partners, a premier national recruitment firm that specializes in delivering top executive, management and leadership talent for the diagnostics, laboratory testing and life sciences industries.
- Interpace Diagnostics
A wholly owned subsidiary of PDI Inc., the company supports the advancement of targeted therapies and personalized medicine via commercializing cutting edge molecular diagnostic tests that bring compelling clinical and financial value to patients. providers, and payers, Mr. Weissman serves on the firm’s Managed Care Advisory Board.
- Coleman Research
Mr. Weissman is designated a expert consultant at the company which connects its corporate clients directly with industry experts, to hear immediate, relevant insights.
- Gerson Lehrman Group
Mr. Weissman serves as a expert healthcare consultant for the primary research and knowledge firm that operates a membership-based platform of subject matter experts who provide independent ad-hoc consulting services to companies around the world.